Literature DB >> 2787326

Effects of transforming growth factor beta and epidermal growth factor on cell proliferation and the formation of bone nodules in isolated fetal rat calvaria cells.

M E Antosz1, C G Bellows, J E Aubin.   

Abstract

When cells enzymatically isolated from fetal rat calvaria (RC cells) are cultured in vitro in the presence of ascorbic acid and Na beta-glycerophosphate, discrete three-dimensional nodules form with the histologic, immunohistochemical, and ultrastructural characteristics of bone (Bellows et al; Calcified Tissue International 38:143-154, 1986; Bhargava et al., Bone, 9:155-163, 1988). Quantitation of the number of bone nodules that forms provides a colony assay for osteoprogenitor cells present in the RC population (Bellows and Aubin, Develop. Biol., 133:8-13, 1989). Continuous culture with either epidermal growth factor (EGF) or transforming growth factor beta (TGF-beta) results in dose-dependent inhibition of bone nodule formation; however, the former causes increased proliferation and saturation density, while the latter reduces both parameters. Addition of EGF (48 h pulse, 2-200 ng/ml) to RC cells at day 1 after plating results in increased proliferation and population saturation density and an increased number of bone nodules formed. Similar pulses at confluence and in postconfluent multilayered cultures when nodules first begin forming (approx. day 11) inhibited bone nodule formation and resulted in a smaller stimulation of cell proliferation. Forty-eight hour pulses of TGF-beta (0.01-1 ng/ml) reduced bone nodule formation and proliferation at all times examined, with pulses on day 1 causing maximum inhibition. The effects of pulses with TGF-beta and EGF on inhibition of nodule formation are independent of the presence of serum in the culture medium during the pulse. The data suggest that whereas EGF can either stimulate or inhibit the formation of bone nodules depending upon the time and duration of exposure, TGF-B inhibits bone nodule formation under all conditions tested. Moreover, these effects on osteoprogenitor cell differentiation do not always correlate with the effects of the growth factors on RC cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2787326     DOI: 10.1002/jcp.1041400225

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  10 in total

1.  Proliferation of osteoclast-like giant cells in a metastatic bone tumor from stomach cancer: report of a case and analysis of the autopsy findings.

Authors:  T Saeki; K Mandai; S Moriwaki; K Yamagami; N Sakamoto; W Takiyama; S Takashima
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

Review 2.  Development of the osteoblast phenotype: molecular mechanisms mediating osteoblast growth and differentiation.

Authors:  J B Lian; G S Stein
Journal:  Iowa Orthop J       Date:  1995

3.  Systemic administration of transforming growth factor-beta 2 prevents the impaired bone formation and osteopenia induced by unloading in rats.

Authors:  M Machwate; E Zerath; X Holy; M Hott; D Godet; A Lomri; P J Marie
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

4.  Inhibition of osteoblastic cell differentiation by lipopolysaccharide extract from Porphyromonas gingivalis.

Authors:  H Kadono; J Kido; M Kataoka; N Yamauchi; T Nagata
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

5.  Biosynthesis of bone proteins [SPP-1 (secreted phosphoprotein-1, osteopontin), BSP (bone sialoprotein) and SPARC (osteonectin)] in association with mineralized-tissue formation by fetal-rat calvarial cells in culture.

Authors:  T Nagata; C G Bellows; S Kasugai; W T Butler; J Sodek
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

6.  Growth factors regulate expression of mineral associated genes in cementoblasts.

Authors:  N E Saygin; Y Tokiyasu; W V Giannobile; M J Somerman
Journal:  J Periodontol       Date:  2000-10       Impact factor: 6.993

7.  Critical roles of the TGF-beta type I receptor ALK5 in perichondrial formation and function, cartilage integrity, and osteoblast differentiation during growth plate development.

Authors:  Tomoya Matsunobu; Kiyoyuki Torigoe; Masaki Ishikawa; Susana de Vega; Ashok B Kulkarni; Yukihide Iwamoto; Yoshihiko Yamada
Journal:  Dev Biol       Date:  2009-06-06       Impact factor: 3.582

8.  Regulation of transformation-sensitive secreted phosphoprotein (SPPI/osteopontin) expression by transforming growth factor-beta. Comparisons with expression of SPARC (secreted acidic cysteine-rich protein).

Authors:  J L Wrana; T Kubota; Q Zhang; C M Overall; J E Aubin; W T Butler; J Sodek
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

9.  Transforming growth factor beta-1 (TGFB1) and peak bone mass: association between intragenic polymorphisms and quantitative ultrasound of the heel.

Authors:  Peter Tzakas; Betty Y L Wong; Alexander G Logan; Laurence A Rubin; David E C Cole
Journal:  BMC Musculoskelet Disord       Date:  2005-06-14       Impact factor: 2.362

10.  TGFβ1-Induced Differentiation of Human Bone Marrow-Derived MSCs Is Mediated by Changes to the Actin Cytoskeleton.

Authors:  Mona Elsafadi; Muthurangan Manikandan; Sami Almalki; Mohammad Mobarak; Muhammad Atteya; Zafar Iqbal; Jamil Amjad Hashmi; Sameerah Shaheen; Nehad Alajez; Musaad Alfayez; Moustapha Kassem; Raed Abu Dawud; Amer Mahmood
Journal:  Stem Cells Int       Date:  2018-02-15       Impact factor: 5.443

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.